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“Everything should be made as simple 
as possible, but not simpler.”
Albert Einstein (1879-1955) 
Percutaneous treatment of complex coronary bi-furcation lesions is a constant challenge for the interventionist. Bifurcation lesions are frequent, 
representing 15% to 20% of all percutaneous coronary 
interventions (PCIs). Their treatment is associated with 
lower procedural success and a higher incidence of 
periprocedural myocardial infarction, stent thrombosis 
and in-stent restenosis, as well as a higher procedure 
cost compared with the treatment of lesions not located 
in bifurcations. Initially, our knowledge was very sparse 
regarding the techniques and steps that are required to 
successfully perform PCI in coronary bifurcation lesions.
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That has changed. Thanks to drug-eluting stents (DES) 
and their obviously lower rate of in-stent restenosis, as 
well as the improvement in stent materials and design, 
it is easier to study and address complex challenges in 
bifurcations. That, in turn, resulted in well-conducted 
and randomised clinical trials in bifurcations, such as 
the NORDIC1–3 clinical trials and the CACTUS4 and BBC 
ONE5 studies, among others.6,7 In addition, meetings 
and organisations have been dedicated to addressing 
bifurcations, such as the European Bifurcation Club and 
the Asian Bifurcation Club, aiming to guide this area 
of  knowledge and address outstanding issues. Likewise, 
many dedicated stents have been developed for this 
type of lesion, such as Axxess, Tryton, Xience SBA, 
and Nile, which may offer better results.
Consequently, some consensuses regarding the use 
of PCI in coronary bifurcation lesions have emerged 
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during recent years. To date, the provisional strategy 
using DES has been the technique of choice wherever 
possible and consists of stenting in the main vessel, 
whereas stent implantation in the side branch is per-
formed only when necessary. This consensus is based 
on large randomised clinical trials reporting that the 
complex approach with systematic implantation of 2 
stents in both branches, main and side, was not better 
than the provisional strategy. The provisional strategy is 
simpler regarding major adverse cardiovascular events 
and resulted in a significant increase in the procedural 
and fluoroscopy time duration, a larger amount of 
contrast used and an increased release of biomarkers 
related to the procedure.1,5,6 Therefore, our stenting 
technique in bifurcations should remain as simple as 
possible. It is still unclear whether the procedure should 
be finalised using kissing-balloon dilation. Although 
the strategies of stenting in the main vessel, with or 
without kissing-balloon dilation, have been associated 
with similar outcomes, kissing-balloon dilation in the 
angiography, especially in patients with true bifurcation 
lesions, has decreased side-branch restenosis from 20% 
to 7.6%.3 Thus, we believe that the kissing-balloon dila-
tion should be used in cases where the lesion remains 
angiographically significant (> 75%) in the side branch 
after stenting of the main vessel.8
Another subject for debate regarding stenting in 
bifurcations refers to the need to perform systematic 
side-branch predilation, especially if it has a significant 
and long lesion (> 5 mm). This issue is addressed in the 
article by Costa et al.,9 published in this issue of the 
Revista Brasileira de Cardiologia Invasiva. This study is a 
subanalysis of a prospective, randomised trial comparing 
the efficacy of the provisional technique versus two-stent 
implantation in 59 patients with a single de novo lesion 
in the coronary artery bifurcation, compromising the 
main vessel and the side branch (called ‘true bifurca-
tion lesions’, lesions 1.1.1, 1.0.1 or 0.1.1, according 
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to Medina classification) with the side-branch lesion 
extending > 5 mm beyond the ostium (or true complex 
bifurcation lesions). In this clinical trial, side-branch 
lesions involved a long segment, with a mean length 
of 9.9 mm to 12.6 mm, significantly longer compared 
with the mean length of side-branch lesions in previ-
ous trials (5.7  mm to 7.5  mm).1–4 Costa et al.9 should 
therefore be congratulated for the careful recruitment 
of patients with severe and complex bifurcation lesions 
and for the accurate description of these lesions. In this 
analysis, the results of systematic side-branch predila-
tion were reported in all cases. Of the 59 patients, 5 
(8.5%) did not have successful side-branch predilation, 
defined as dissection, TIMI flow < 3 or residual stenosis 
>  50%. These 5 patients were subsequently excluded 
from the randomised study where treatment was decided 
at the surgeon’s discretion. In 4 of these 5 patients 
(80%), the failure was due to dissection successfully 
treated with the two-stent strategy, whereas one of them 
had significant residual stenosis in a calcified lesion 
that could not be treated. There were no significant 
differences in terms of lesion extension, (the mean 
lesion diameter or stenosis diameter between the 
groups with successful vs. unsuccessful predilation), 
although the study most likely had little power to detect 
such differences. A multivariate analysis identified the 
severity of the side-branch stenosis diameter as a pre-
dictor of predilation failure in this branch. Costa et 
al.9 have therefore demonstrated a dilemma: the more 
severe stenoses would benefit the most from predila-
tion, but they also have the greatest potential for failure 
after predilation.
The non-randomised nature of side-branch predi-
lation and the small number of patients in the study 
by Costa et al.9 may prevent more consistent conclu-
sions regarding the practice in daily routine. Other 
randomised studies are certainly needed. However, 
although the side-branch lesions were smaller in 
the NORDIC study when compared with the study 
by Costa et al.9 (mean length of lesions of 6  mm to 
6.4  mm vs. 9.9  mm to 12.6  mm, respectively), the 
prerequisite in the NORDIC study to prevent pretreat-
ment with a conventional balloon or a cutting balloon 
of the segments not covered by the stent resulted 
in lower cross-over from the simpler technique to 
the more complex one in the main vessel and side-
branch stenting in 4.3% of patients. In the study by 
Costa et al.,9 the predilation resulted in a complex 
(or unsuccessful) stent implant in 8.5% of cases. The 
rate of cross-over in the randomised part of this trial, 
in addition to these 8.5%, is still unknown. In the 
CACTUS study, for instance, where the side-branch 
predilation was performed in 90.8% of patients, the 
rate of cross-over from a simple provisional implant 
to complex crush stenting was 31%.4 Therefore, it 
appears that side-branch predilation has implica-
tions. Similarly, bifurcation registries, such as TULIPE, 
demonstrated that side-branch predilation is not a 
predictor for successful recrossing of the guidewire 
through the stent structure or angiographic success 
of the side branch.10
We do not have enough data to advocate routine 
side-branch predilation when the intention is to use 
the provisional technique of stenting in bifurcation 
lesions. Maybe we could adhere to Einstein’s reduc-
tionism (‘Everything should be made as simple as 
possible…’), simplifying our procedure and avoiding 
predilation whenever possible. However, the procedure 
should not be simplified to the extreme (‘...but not 
simpler’) but performed in such a way that, if the 
side branch is compromised (TIMI flow <  3 in side 
branch ≥  2.5  mm, fractional reserve flow <  0.75, 
residual stenosis > 75%, dissection) before implanting 
a stent, side-branch predilation may be performed 
to restore adequate flow, taking into account that 
the two-stent strategy may be necessary. This is not 
based on guidelines, which will be defined in future 
studies. As Einstein also suggested, ‘The important 
thing is not to stop questioning’.
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